Page 174 - 2021_05-Haematologica-web
P. 174
O. Moser et al.
A
B
C
Figure 2. Estimated cumulative inci- dence of second malignant neo- plasms in patients with non-Hodgkin lymphoma (NHL) <15 years of age at diagnosis, treated in one of the con- secutive NHL-BFM studies NHL-BFM- 81, through EURO-LB-02/B-NHL-04. (A) Cumulative incidence of second malignant neoplasms (SMN) for all analyzed patients (5.3%±0.7). (B) Cumulative incidence of SMN for patients with lymphoblastic lym- phoma (LBL) (9.3±1.9) compared to patients with other NHL (Non-LBL NHL) (3.9±0.8). (C) Cumulative inci- dence of SMN for NHL-patients with known cancer-predisposing condition (CPC) (19.9±7.2) compared to patients without known CPC (4.9±0.7). SE: standard error.
1394
haematologica | 2021; 106(5)
